Get the Stockscreener App
209.96
2.20%
4.52
After Hours:
209.96
Iqvia Holdings Inc stock is traded at $209.96, with a volume of 1.78M.
It is up +2.20% in the last 24 hours and up +5.36% over the past month.
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
See More
Previous Close:
$205.44
Open:
$218.1
24h Volume:
1.78M
Relative Volume:
1.11
Market Cap:
$38.11B
Revenue:
$15.32B
Net Income/Loss:
$1.41B
P/E Ratio:
27.55
EPS:
7.62
Net Cash Flow:
$1.96B
1W Performance:
+4.05%
1M Performance:
+5.36%
6M Performance:
-11.51%
1Y Performance:
-2.53%
1-Day Range:
$208.19
$220.00
1-Week Range:
$195.99
$220.00
52-Week Range:
$187.62
$261.73
Iqvia Holdings Inc Stock (IQV) Company Profile
Name
Iqvia Holdings Inc
Sector
Industry
Phone
919-998-2000
Address
2400 ELLIS ROAD, DURHAM, NC
Compare IQV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IQV
Iqvia Holdings Inc
|
209.96 | 38.11B | 15.32B | 1.41B | 1.96B | 7.62 |
|
TMO
Thermo Fisher Scientific Inc
|
572.71 | 219.06B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
210.01 | 151.02B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
147.64 | 42.12B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IDXX
Idexx Laboratories Inc
|
460.56 | 37.71B | 3.84B | 866.24M | 792.60M | 10.37 |
Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-03-25 | Downgrade | BTIG Research | Buy → Neutral |
| Dec-20-24 | Initiated | Stephens | Overweight |
| Oct-14-24 | Initiated | Redburn Atlantic | Buy |
| Sep-04-24 | Initiated | RBC Capital Mkts | Outperform |
| Jul-24-24 | Downgrade | Jefferies | Buy → Hold |
| Jun-06-24 | Initiated | Goldman | Buy |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Feb-15-24 | Downgrade | Guggenheim | Buy → Neutral |
| Feb-13-24 | Initiated | BTIG Research | Buy |
| Nov-02-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Mar-17-23 | Initiated | Truist | Buy |
| Dec-06-22 | Initiated | Cowen | Outperform |
| Nov-17-22 | Downgrade | Citigroup | Buy → Neutral |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jul-15-22 | Initiated | SVB Leerink | Outperform |
| May-24-22 | Initiated | Guggenheim | Buy |
| Apr-29-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Apr-16-21 | Upgrade | Stephens | Equal-Weight → Overweight |
| Mar-08-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jul-07-20 | Initiated | Stephens | Equal-Weight |
| Mar-02-20 | Initiated | Deutsche Bank | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Dec-13-19 | Upgrade | CFRA | Sell → Hold |
| Nov-14-19 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jun-21-19 | Upgrade | Mizuho | Neutral → Buy |
| May-28-19 | Initiated | SVB Leerink | Outperform |
| Jan-18-19 | Upgrade | Jefferies | Hold → Buy |
| Oct-09-18 | Initiated | UBS | Buy |
| Oct-02-18 | Reiterated | Robert W. Baird | Outperform |
| Jul-25-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-25-18 | Reiterated | Stifel | Buy |
| Jul-03-18 | Upgrade | Raymond James | Outperform → Strong Buy |
| Apr-13-18 | Upgrade | Goldman | Neutral → Buy |
| Mar-07-18 | Upgrade | SunTrust | Hold → Buy |
| Jan-19-18 | Initiated | Evercore ISI | Outperform |
View All
Iqvia Holdings Inc Stock (IQV) Latest News
When (IQV) Moves Investors should Listen - Stock Traders Daily
IQVIA sees 2025 revenue growth of 4%-7% amid strong demand recovery - MSN
IQVIA: Q4 Earnings Snapshot - mySA
Calamos Advisors LLC Lowers Stock Position in IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat
IQVIA (IQV) to Release Quarterly Earnings on Thursday - MarketBeat
IQVIA (NYSE:IQV) Exceeds Q4 Expectations, Stock Soars - Barchart
IQVIA Earnings & Revenues Surpass Estimates in Q4, Increase Y/Y - Yahoo Finance
IQVIA Delivers Solid Q4 Growth Despite 'Choppy' Market Conditions - Benzinga
Earnings call transcript: IQVIA Q4 2024 beats expectations, stock rises - Investing.com
IQVIA Reports Fourth-Quarter and Full-Year 2024 Results; Reaffirms Full-Year 2025 Guidance - BioSpace
IQVIA Exceeds Expectations With Strong Fourth-Quarter Performance - Finimize
Here's What Key Metrics Tell Us About IQVIA (IQV) Q4 Earnings - Yahoo Finance
IQVIA beats quarterly results estimates on analytics services demand -February 06, 2025 at 08:28 am EST - Marketscreener.com
IQVIA (NYSE:IQV) Exceeds Q4 Expectations, Stock Soars By Stock Story - Investing.com Canada
IQVIA Holdings (IQV) Beats Q4 Earnings and Revenue Estimates - Yahoo Finance
IQVIA Holdings Inc (IQV) Q4 Earnings: EPS of $2.42 Beats Estimat - GuruFocus.com
IQVIA Holdings earnings beat by $0.01, revenue topped estimates - Investing.com Canada
IQVIA: Q4 Earnings Snapshot -February 06, 2025 at 07:18 am EST - Marketscreener.com
Earnings Flash (IQV) IQVIA Holdings Posts Q4 Revenue $3.96B, vs. FactSet Est of $3.93B - Marketscreener.com
Earnings Flash (IQV) IQVIA Holdings Posts Q4 Adjusted EPS $3.12, vs. FactSet Est of $3.11 - Marketscreener.com
IQVIA Gears Up to Report Q4 Earnings: What's in Store for the Stock? - MSN
IQVIA (IQV) Q4 Earnings Report Preview: What To Look For - Barchart
IQVIA (IQV) Q4 Earnings Report Preview: What To Look For By Stock Story - Investing.com Canada
Morgan Stanley Adjusts IQVIA Holdings' Price Target to $245 From $265 -February 05, 2025 at 11:12 am EST - Marketscreener.com
Here's Why IQVIA Holdings (IQV) is a Strong Value Stock - MSN
Healthcare Giant IQVIA Claims #1 Spot in Fortune Rankings, Dominates 4 Key Categories - StockTitan
GDS Wealth Management Increases Holdings in IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat
Country Trust Bank Has $40.24 Million Holdings in IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat
Swedbank AB Sells 3,232 Shares of IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat
Robeco Institutional Asset Management B.V. Cuts Stock Holdings in IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat
BTIG cuts IQVIA stock rating to neutral amid sector headwinds - MSN
Analyst Expectations For IQVIA Hldgs's Future - Benzinga
IQVIA (NYSE:IQV) Given New $235.00 Price Target at Barclays - MarketBeat
IQVIA (NYSE:IQV) Rating Lowered to "Neutral" at BTIG Research - MarketBeat
Unlocking Q4 Potential of IQVIA (IQV): Exploring Wall Street Estimates for Key Metrics - Yahoo Finance
Barclays Adjusts IQVIA Holdings Price Target to $235 From $255, Maintains Overweight Rating - Marketscreener.com
Oregon Pacific Wealth Management LLC Makes New Investment in IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat
BTIG cuts IQVIA stock rating to neutral amid sector headwinds By Investing.com - Investing.com Canada
BTIG Downgrades IQVIA Holdings to Neutral From Buy -February 03, 2025 at 06:00 am EST - Marketscreener.com
SYM FINANCIAL Corp Makes New $318,000 Investment in IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat
Hanson & Doremus Investment Management Acquires 2,180 Shares of IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat
Forsta AP Fonden Sells 14,900 Shares of IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat
Smith Group Asset Management LLC Acquires New Holdings in IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat
R Squared Ltd Invests $360,000 in IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat
Mediolanum International Funds Ltd Sells 124,019 Shares of IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat
Fifth Third Bancorp Buys 1,521 Shares of IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat
Biosimilar medicines: the intersection of access, affordability, and innovation -January 31, 2025 at 10:30 am EST - Marketscreener.com
Highland Capital Management LLC Buys Shares of 6,393 IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat
Iqvia Holdings Inc Stock (IQV) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):